E
ZyVersa Therapeutics, Inc. ZVSA
$0.7899 -$0.0111-1.39%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -41.55% -32.59% 7.89% 39.72% 132.72%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -46.01% -44.01% -15.95% 4.25% 71.06%
Operating Income 46.01% 44.01% 15.95% -4.25% -71.06%
Income Before Tax 77.92% 77.59% -574.65% -624.75% -769.44%
Income Tax Expenses 93.89% 93.89% -369.19% -1,169.08% --
Earnings from Continuing Operations 76.20% 75.86% -601.11% -596.03% -685.30%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 76.20% 75.86% -601.11% -596.03% -685.30%
EBIT 46.01% 44.01% 15.95% -4.25% -71.06%
EBITDA 46.03% 44.03% 15.96% -4.25% -71.13%
EPS Basic 96.24% 95.17% -392.17% -581.30% -559.49%
Normalized Basic EPS 94.07% 86.20% 44.60% -130.01% -124.00%
EPS Diluted 96.24% 95.17% -392.17% -581.30% -559.49%
Normalized Diluted EPS 94.07% 86.20% 44.60% -130.01% -124.00%
Average Basic Shares Outstanding -97.09% -98.06% -98.91% -99.57% 848.73%
Average Diluted Shares Outstanding -97.09% -98.06% -98.91% -99.57% 848.73%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings